Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells

Cancer Cell

Volumn 6, Issue 6, 2004, Pages 625-630

  Valsesia Wittmann, Sandrine ^a   Magdeleine, Maud ^a   Dupasquier, Sébastien ^a   Garin, Elisabeth ^a   Jallas, Anne Catherine ^a   Combaret, Valérie ^a   Krause, Alexander ^b   Leissner, Philippe ^b   Puisieux, Alain ^a  

^a UNIVERSITÉ LYON 1   (France)

^b BIOMÉRIEUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TWIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA MICROARRAY; GENE AMPLIFICATION; IMMUNOBLOTTING; MOUSE; NEUROBLASTOMA; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 10944221249     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.09.033     Document Type: Article

References (27)

1. Arango D., Corner G.A., Wadler S., Catalano P.J., Augenlicht L.H. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo. Cancer Res. 61:2001;4910-4915
2. Brodeur G.M. Neuroblastoma. biological insights into clinical enigma Nat. Rev. Cancer. 3:2003;203-216
3. Brodeur G.M., Seeger R.C., Schwab M., Varmus H.E., Bishop J.M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 224:1984;1121-1124
4. Chen Z.F., Behringer R.R. Twist is required in head mesenchyme for cranial neural tube morphogenesis. Genes Dev. 9:1995;686-699
5. el Ghouzzi V., Le Merrer M., Perrin-Schmitt F., Lajeunie E., Benit P., Renier D., Bourgeois P., Bolcato-Bellemin A.L., Munnich A., Bonaventure J. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 15:1997;42-46
6. Elson A., Deng C., Campos-Torres J., Donehower L.A., Leder P. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene. 11:1995;181-190
7. Evan G.I., Wyllie A.H., Gilbert C.S., Littlewood T.D., Land H., Brooks M., Waters C.M., Penn L.Z., Hancock D.C. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:1992;119-128
8. Fulda S., Lutz W., Schwab M., Debatin K.M. MycN sensitizes neuroblastoma cells for drug-induced apoptosis. Oncogene. 18:1999;1479-1486
9. Hamamori Y., Wu H.Y., Sartorelli V., Kedes L. The basic domain of myogenic basic helix-loop-helix (bHLH) proteins is the novel target for direct inhibition by another bHLH protein, Twist. Mol. Cell. Biol. 17:1997;6563-6573
10. Hebrok M., Wertz K., Fuchtbauer E.M. M-twist is an inhibitor of muscle differentiation. Dev. Biol. 165:1994;537-544
11. Hermeking H., Eick D. Mediation of c-Myc-induced apoptosis by p53. Science. 265:1994;2091-2093
12. Hogarty M.D. The requirement for evasion of programmed cell death in neuroblastomas with MYCN amplification. Cancer Lett. 197:2003;173-179
13. Howard T.D., Paznekas W.A., Green E.D., Chiang L.C., Ma N., Ortiz de Luna R.I., Garcia Delgado C., Gonzalez-Ramos M., Kline A.D., Jabs E.W. Mutations in TWIST, a basic helix-loop-helix transcription factor, in Saethre-Chotzen syndrome. Nat. Genet. 15:1997;36-41
14. Leptin M., Grunewald B. Cell shape changes during gastrulation in Drosophila. Development. 110:1990;73-84
15. Lutz W., Stohr M., Schurmann J., Wenzel A., Lohr A., Schwab M. Conditional expression of N-myc in human neuroblastoma cells increases expression of α-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene. 4:1996;803-812
16. Maestro R., Dei Tos A.P., Hamamori Y., Krasnokutsky S., Sartorelli V., Kedes L., Doglioni C., Beach D.H., Hannon G.J. Twist is a potential oncogene that inhibits apoptosis. Genes Dev. 13:1999;2207-2217
17. Olson E.N., Klein W.H. bHLH factors in muscle development. dead lines and commitments, what to leave in and what to leave out Genes Dev. 8:1994;1-8
18. O'Rourke M.P., Soo K., Behringer R.R., Hui C.C., Tam P.P. Twist plays an essential role in FGF and SHH signal transduction during mouse limb development. Dev. Biol. 248:2002;143-156
19. Rosivatz E., Becker I., Specht K., Fricke E., Luber B., Busch R., Hofler H., Becker K.F. Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am. J. Pathol. 161:2002;1881-1891
20. Schwab M., Varmus H., Bishop J.M. Human N-Myc gene contributes to neoplastic transformation of mammalian cells in culture. Nature. 316:1985;160-162
21. Sosic D., Richardson J.A., Yu K., Ornitz D.M., Olson E.N. Twist regulates cytokine gene expression through a negative feedback loop that represses NF-κB activity. Cell. 112:2003;169-180
22. Strasser A., Harris A.W., Bath M.L., Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 348:1990;331-333
23. Thiele C.J. Neuroblastoma. Masters J.R.W., Palsson B. Human Cell Culture, Volume 1. 1999;21-53 Kluwer Academic Publishers, London
24. Vogan K., Bernstein M., Leclerc J.M., Brisson L., Brossard J., Brodeur G.M., Pelletier J., Gros P. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res. 53:1993;5269-5273
25. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell. 117:2004;927-939
26. Yousfi M., Lasmoles F., El Ghouzzi V., Marie P.J. Twist haploinsufficiency in Saethre-Chotzen syndrome induces calvarial osteoblast apoptosis due to increased TNFα expression and caspase-2 activation. Hum. Mol. Genet. 11:2002;359-369
27. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., Roussel M.F. Myc signalling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12:1998;2424-2433